Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
Abstract Background Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by the hallmark finding of cerebral amyloid deposition. Many researchers have tried to predict the existence of cerebral amyloid deposition by using easily accessible blood plasma samples, but the...
Main Authors: | Jong-Chan Park, Keum Sim Jung, Jiyeong Kim, Ji Sung Jang, Sunghoon Kwon, Min Soo Byun, Dahyun Yi, Gihwan Byeon, Gijung Jung, Yu Kyeong Kim, Dong Young Lee, Sun-Ho Han, Inhee Mook-Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-020-00751-x |
Similar Items
-
R4Alz-Revised: A Tool Able to Strongly Discriminate ‘Subjective Cognitive Decline’ from Healthy Cognition and ‘Minor Neurocognitive Disorder’
by: Eleni Poptsi, et al.
Published: (2023-01-01) -
The QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer’s Disease
by: Hunjong Na, et al.
Published: (2023-07-01) -
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
by: Anders Sandberg, et al.
Published: (2022-12-01) -
Therapeutic role of MSCs-derived exosomes for Alzheimer's disease
by: Sanaa M.R. Wahba, et al.
Published: (2020-12-01) -
Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease
by: Jong-Chan Park, et al.
Published: (2023-05-01)